Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 386

    1.

    Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation.

    Cruz R, Quintana-Hau JD, González JR, Tornero-Montaño R, Baiza-Durán LM, Vega L.

    Br J Ophthalmol. 2008 Jan;92(1):120-5. Epub 2007 Oct 25.PMID: 17962388 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.

    Engelhardt G, Bögel R, Schnitzler C, Utzmann R.

    Biochem Pharmacol. 1996 Jan 12;51(1):29-38.PMID: 8534265 [PubMed - indexed for MEDLINE]Related articles

    4.

    A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats.

    Oba M, Miwa K, Fujimura T, Harada S, Sasaki S, Oyama K, Ohta T, Hattori T.

    Cancer. 2009 Jan 15;115(2):454-64.PMID: 19110997 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cyclooxygenase-2 inhibition and experimental colitis: beneficial effects of phosphorothioated antisense oligonucleotide and meloxicam.

    Khan I, Al-Awadi FM, Thomas N, Haridas S, Anim JT.

    Scand J Gastroenterol. 2002 Dec;37(12):1428-36.PMID: 12523593 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application.

    Gupta SK, Bansal P, Bhardwaj RK, Jaiswal J, Velpandian T.

    Skin Pharmacol Appl Skin Physiol. 2002 Mar-Apr;15(2):105-11.PMID: 11867967 [PubMed - indexed for MEDLINE]Related articles

    8.

    Protective effects of meloxicam on aluminum overload-induced cerebral damage in mice.

    Jun-Qing Y, Bei-Zhong L, Bai-Cheng H, Qi-Qin Z.

    Eur J Pharmacol. 2006 Oct 10;547(1-3):52-8. Epub 2006 Jul 25.PMID: 16928369 [PubMed - indexed for MEDLINE]Related articles

    9.

    COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats.

    Oliveira TM, Sakai VT, Machado MA, Dionísio TJ, Cestari TM, Taga R, Amaral SL, Santos CF.

    J Periodontol. 2008 Jun;79(6):1062-9.PMID: 18533784 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of diclofenac on prostaglandin liberation in the rabbit after photorefractive keratectomy.

    Tomas-Barberan S, Törngren L, Lundberg K, Fagerholm P, Rolfsen W.

    J Refract Surg. 1997 Mar-Apr;13(2):154-7.PMID: 9109071 [PubMed - indexed for MEDLINE]Related articles

    11.

    Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.

    Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM.

    Inflammation. 2000 Aug;24(4):357-70.PMID: 10850857 [PubMed - indexed for MEDLINE]Related articles

    12.

    Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.

    Quintana R, Kopcow L, Marconi G, Young E, Yovanovich C, Paz DA.

    Fertil Steril. 2008 Oct;90(4 Suppl):1511-6. Epub 2007 Dec 31.PMID: 18166186 [PubMed - indexed for MEDLINE]Related articles

    13.

    Ocular inflammation models by topical application: croton-oil induced uveitis.

    Villena C, Vivas JM, Villar AM.

    Curr Eye Res. 1999 Jan;18(1):3-9.PMID: 10075197 [PubMed - indexed for MEDLINE]Related articles

    14.

    Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.

    Naruse T, Nishida Y, Hosono K, Ishiguro N.

    Carcinogenesis. 2006 Mar;27(3):584-92. Epub 2005 Oct 11.PMID: 16219634 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Synergistic anti-inflammatory interaction between meloxicam and aminoguanidine hydrochloride in carrageenan-induced acute inflammation in rats.

    Dudhgaonkar SP, Tandan SK, Bhat AS, Jadhav SH, Kumar D.

    Life Sci. 2006 Feb 2;78(10):1044-8. Epub 2005 Aug 16.PMID: 16109432 [PubMed - indexed for MEDLINE]Related articles

    17.

    Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice.

    Narita M, Shimamura M, Imai S, Kubota C, Yajima Y, Takagi T, Shiokawa M, Inoue T, Suzuki M, Suzuki T.

    Neuroscience. 2008 Mar 18;152(2):477-86. Epub 2007 Nov 12.PMID: 18262365 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery.

    Baiza-Duran LM, Quintana-Hau J, Tornero-Montaño R, Ortiz MI, Castañeda-Hernández G, Alanis-Villarreal L, Avalos-Urzua G, Bustos-Zermeño R, Domene-Hinojosa JL, Gómez-Bastar P, Ibañez-Hernandez MA, Morales-Gómez ME, Velasco-Gallegos G, Villar-Kuri J.

    Int J Clin Pharmacol Ther. 2009 Feb;47(2):89-95.PMID: 19203564 [PubMed - indexed for MEDLINE]Related articles

    19.

    [The effect of interleukin-1 on ocular inflammation in rabbit ocular tissue]

    Katayama T.

    Nippon Ganka Gakkai Zasshi. 1991 Jul;95(7):635-43. Japanese. PMID: 1927742 [PubMed - indexed for MEDLINE]Related articles

    20.

    Anti-inflammatory drugs ameliorate opposite enzymatic changes in ileal 5-hydroxytryptamine metabolism in the delayed phase after cisplatin administration to rats.

    Ju C, Hamaue N, Machida T, Liu Y, Iizuka K, Wang Y, Minami M, Hirafuji M.

    Eur J Pharmacol. 2008 Jul 28;589(1-3):281-7. Epub 2008 May 6.PMID: 18534574 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data